EPISODE · May 8, 2025 · 15 MIN
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
from Oncology Brothers: Practice-Changing Cancer Discussions · host Oncology Brothers
In this episode of the Oncology Brothers podcast, Drs. Rahul & Rohit Gosain wrap up their three-part CME series on HER2-positive biliary tract cancer. Joined by Dr. Rachna Shroff, they delved into the critical topic of managing adverse events associated with treatments like TDXD and Zanidatamab.The discussion covered:• Overview of the treatment landscape for biliary tract cancer• Common side effects of TDXD, including interstitial lung disease, nausea, and fatigue• Management strategies for adverse events, including dose reductions and supportive care• Insights on Zanidatamab, its side effects, and infusion-related reactions• The importance of biomarker testing and patient-centered care in treatment decisionsTune in to gain valuable insights on how to improve patient quality of life while navigating the complexities of HER2-positive biliary tract cancer treatments.Follow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!
What this episode covers
In this episode of the Oncology Brothers podcast, Drs. Rahul & Rohit Gosain wrap up their three-part CME series on HER2-positive biliary tract cancer. Joined by Dr. Rachna Shroff, they delved into the critical topic of managing adverse events associated with treatments like TDXD and Zanidatamab.The discussion covered:• Overview of the treatment landscape for biliary tract cancer• Common side effects of TDXD, including interstitial lung disease, nausea, and fatigue• Management strategies for adverse events, including dose reductions and supportive care• Insights on Zanidatamab, its side effects, and infusion-related reactions• The importance of biomarker testing and patient-centered care in treatment decisionsTune in to gain valuable insights on how to improve patient quality of life while navigating the complexities of HER2-positive biliary tract cancer treatments.Follow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!
NOW PLAYING
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m